Universal immunization of infants against Neisseria meningitidis: Addressing the remaining unmet medical need in the prevention of meningitis and septicemia

Human Vaccines

Volumn 6, Issue 2, 2010, Pages 219-223

  Stoddard, Jeffrey ^a   Dougherty, Nancy ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (United States)

Author keywords

Bacterial meningitis; Childhood immunization; Invasive meningococcal disease; Neisseria meningitidis; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B NEISSERIA MENGINGITIDIS SEROGROUP C Y TETANUS TOXOID CONJUGATE VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; QUADRIVALENT NONADJUVANTED MENINGOCOCCAL GLYCOCONJUGATE VACCINE; UNCLASSIFIED DRUG;

BACTERIAL MENINGITIS; CHILD; CLINICAL TRIAL; DIPHTHERIA; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; NEISSERIA MENINGITIDIS; NOTE; PERTUSSIS; POLIOMYELITIS; PREVENTIVE HEALTH SERVICE; SEPSIS; SEPTICEMIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; SEPSIS; VACCINATION;

EID: 77953626877     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.2.10330     Document Type: Note

References (27)

1. Centers for Disease Control and Prevention (CDC). Impact of vaccines universally recommended for children - United States, 1900-1998. JAMA 1999; 281:1482-3.
2. Roush SW, Murphy TV. Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007; 298:2155-63.
3. Hall-Baker PA, Nieves E Jr, Jajosky RA, Adams DA, Sharp P, Anderson WJ, et al. Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases-United States, 2007. MMWR 2009; 56:1-94. http://www.cdc.gov/MMWR/ summary.html. Accessed 2009.
4. Centers for Disease Control and Prevention (CDC). Preventing Pneumococcal Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000; 49:1-38.
5. National Center for Health Statistics. Vital Statistics of the United States, 1959. Volume II, Mortality Statistics for the United States and Each State 1964; 60. http://www.cdc.gov/nchs/products/vsus.htm. Accessed 2009.
6. Fischer TK, Viboud C, Parashar U, Malek M, Steiner C, Glass R, Simonsen L. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis 2007; 195:1117-25.
7. Centers for Disease Control and Prevention (CDC). Recommended immunization schedules for persons aged 0-18 years - United States, 2009. MMWR 2009; 57:1-4.
8. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990; 162:1316-23.
9. Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet 2003; 361:2139-48.
10. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Atkinson W, Wolfe S, Hamborsky J, McIntyre L, eds. 11th ed. Chapter 8. Haemophilus influenzae type b disease. Washington DC: Public Health Foundation, 2009. http://www.cdc.gov/vaccines/pubs/pinkbook/pink- chapters.htm and slides http://www.cdc.gov/vaccines/pubs/pinkbook/pinkslides. htm. Accessed 2009.
11. th ed. Chapter 15. Pneumococcal disease. Washington DC: Public Health Foundation, 2009. http://www.cdc.gov/vaccines/pubs/pinkbook/pink- chapters.htm and slides http://www.cdc.gov/vaccines/pubs/pinkbook/pink-slides. htm. Accessed 2009.
12. th ed. Chapter 12. Meningococcal disease. Washington DC: Public Health Foundation, 2009. http://www.cdc.gov/vaccines/pubs/pinkbook/pink- chapters.htm. Accessed 2009.
13. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network - Neisseria meningitidis, 1997-2008. http://www.cdc.gov/abcs/survreports.htm. Accessed 2009.
14. Shepard CW, Rosenstein NE, Fischer M. Active Bacterial Core Surveillance Team. Neonatal meningococcal disease in the United States, 1990 to 1999. Pediatr Infect Dis J 2003; 22:418-22.
15. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report: Emerging Infections Program Network - Neisseria meningitides, 2007. http://www.cdc.gov/abcs/survreports.htm. Accessed 2009.
16. Bilukha OO, Rosenstein N. National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54:1-21.
17. Sharip A, Sorvillo F, Redelings MD, Mascola L, Wise M, Nguyen DM. Population-based analysis of meningococcal disease mortality in the United States: 1990-2002. Pediatr Infect Dis J 2006; 25:191-4.
18. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4). MMWR 2008; 57:462-5.
19. Rennels M, King J Jr, Ryall R, Papa T, Froeschle J. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine in infants. Pediatr Infect Dis J 2004; 23:429-35.
20. Centers for Disease Control and Prevention. Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR 2007; 56:794-5.
21. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices. Recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2-10 years at increased risk for invasive meningococcal disease. MMWR 2007; 56:1265-6.
22. Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C, et al. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Vaccine 2007; 25:8487-99.
23. Perrett KP, Snape MD, Ford KJ, John TM, Yu LM, Langley JM, et al. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants. Pediatr Infect Dis J 2009; 28:186-93.
24. Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, et al. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. JAMA 2008; 299:173-84.
25. Cortese MM, Parashar UD. Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58:1-25.
26. th ed. Chapter 17. Rotavirus disease. Washington DC: Public Health Foundation, 2009. http://www.cdc.gov/vaccines/pubs/pinkbook/pink- chapters.htm. Accessed 2009.
27. Reef SE, Cochi SL. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin Infect Dis 2006; 43:123-5.